Shopping Cart 0
Cart Subtotal
USD 0

Australia Neurology Devices Market Outlook to 2023-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 11990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 17985

Details

Australia Neurology Devices Market Outlook to 2023-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Summary

GlobalData's new report, "Australia Neurology Devices Market Outlook to 2023", provides key market data on the Australia Neurology Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Neurology Devices market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the Australia Neurology Devices market.

Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC, LivaNova PLC and Others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Neurology Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 10

3 Neurology Devices Market, Australia 13

3.1 Neurology Devices Market, Australia, Revenue ($m), 2009-2016 13

3.2 Neurology Devices Market, Australia, Revenue ($m), 2016-2023 15

3.3 Neurology Devices Market, Australia, Volume (Units), 2009-2016 17

3.4 Neurology Devices Market, Australia, Volume (Units), 2016-2023 19

3.5 Neurology Devices Market, Australia, Company Share by Revenue ($m), 2016 21

4 CSF Management Market, Australia 23

4.1 CSF Management Market, Australia, Revenue Mix ($m), 2016 23

4.2 CSF Management Market, Australia, Segment Contribution (%), 2016 24

4.3 CSF Management Market, Australia, Revenue ($m), 2009-2016 25

4.4 CSF Management Market, Australia, Revenue ($m), 2016-2023 27

4.5 CSF Management Market, Australia, Volume (Units), 2009-2016 29

4.6 CSF Management Market, Australia, Volume (Units), 2016-2023 31

4.7 CSF Management Market, Australia, Distribution Share by Revenue ($m), 2015-2016 33

4.8 CSF Management Market, Australia, Company Share by Revenue ($m), 2016 34

5 Interventional Neurology Market, Australia 36

5.1 Interventional Neurology Market, Australia, Revenue Mix ($m), 2016 36

5.2 Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37

5.3 Interventional Neurology Market, Australia, Revenue ($m), 2009-2016 38

5.4 Interventional Neurology Market, Australia, Revenue ($m), 2016-2023 40

5.4.1 Embolization and Coiling Devices Market, Australia, Revenue ($m), by Segment, 2009-2016 42

5.4.2 Navigational System Market, Australia, Revenue ($m), by Segment, 2009-2016 44

5.4.3 Embolization and Coiling Devices Market, Australia, Revenue ($m), by Segment, 2016-2023 46

5.4.4 Navigational System Market, Australia, Revenue ($m), by Segment, 2016-2023 48

5.5 Interventional Neurology Market, Australia, Volume (Units), 2009-2016 50

5.6 Interventional Neurology Market, Australia, Volume (Units), 2016-2023 52

5.6.1 Embolization and Coiling Devices Market, Australia, Volume (Units), by Segment, 2009-2016 54

5.6.2 Navigational System Market, Australia, Volume (Units), by Segment, 2009-2016 56

5.6.3 Embolization and Coiling Devices Market, Australia, Volume (Units), by Segment, 2016-2023 58

5.6.4 Navigational System Market, Australia, Volume (Units), by Segment, 2016-2023 60

5.7 Interventional Neurology Market, Australia, Distribution Share by Revenue ($m), 2015-2016 62

5.8 Interventional Neurology Market, Australia, Company Share by Revenue ($m), 2016 63

6 Neurological Diagnostic Equipment Market, Australia 65

6.1 Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2016 65

6.2 Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66

6.3 Neurological Diagnostic Equipment Market, Australia, Revenue ($m), 2009-2016 67

6.4 Neurological Diagnostic Equipment Market, Australia, Revenue ($m), 2016-2023 69

6.5 Neurological Diagnostic Equipment Market, Australia, Volume (Units), 2009-2016 71

6.6 Neurological Diagnostic Equipment Market, Australia, Volume (Units), 2016-2023 73

6.7 Neurological Diagnostic Equipment Market, Australia, Distribution Share by Revenue ($m), 2015-2016 75

6.8 Neurological Diagnostic Equipment Market, Australia, Company Share by Revenue ($m), 2016 76

7 Neurostimulation Devices Market, Australia 78

7.1 Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2016 78

7.2 Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79

7.3 Neurostimulation Devices Market, Australia, Revenue ($m), 2009-2016 80

7.4 Neurostimulation Devices Market, Australia, Revenue ($m), 2016-2023 82

7.5 Neurostimulation Devices Market, Australia, Volume (Units), 2009-2016 84

7.6 Neurostimulation Devices Market, Australia, Volume (Units), 2016-2023 86

7.7 Neurostimulation Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 88

7.8 Neurostimulation Devices Market, Australia, Company Share by Revenue ($m), 2016 89

8 Neurosurgical Products Market, Australia 91

8.1 Neurosurgical Products Market, Australia, Revenue Mix ($m), 2016 91

8.2 Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92

8.3 Neurosurgical Products Market, Australia, Revenue ($m), 2009-2016 93

8.4 Neurosurgical Products Market, Australia, Revenue ($m), 2016-2023 95

8.5 Neurosurgical Products Market, Australia, Volume (Units), 2009-2016 97

8.6 Neurosurgical Products Market, Australia, Volume (Units), 2016-2023 99

8.7 Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), 2015-2016 101

8.8 Neurosurgical Products Market, Australia, Company Share by Revenue ($m), 2016 102

9 Radiosurgery Market, Australia 104

9.1 Radiosurgery Market, Australia, Revenue ($m), 2009-2016 104

9.2 Radiosurgery Market, Australia, Volume (Units), 2009-2016 106

9.3 Radiosurgery Market, Australia, Average Price ($), 2009-2016 108

10 Overview of Key Companies in Australia, Neurology Devices Market 109

10.1 Medtronic Plc 109

10.1.1 Company Overview 109

10.2 B. Braun Melsungen AG 109

10.2.1 Company Overview 109

10.3 Natus Medical Incorporated 109

10.3.1 Company Overview 109

10.4 Integra LifeSciences Holdings Corp 109

10.4.1 Company Overview 109

10.5 Stryker Corporation 110

10.5.1 Company Overview 110

10.6 DePuy Synthes Inc 110

10.6.1 Company Overview 110

10.7 Terumo Corp 110

10.7.1 Company Overview 110

10.8 Compumedics Ltd 110

10.8.1 Company Overview 110

10.9 St. Jude Medical LLC 111

10.9.1 Company Overview 111

10.10 Nihon Kohden Corp 111

10.10.1 Company Overview 111

10.11 LivaNova PLC 111

10.11.1 Company Overview 111

10.12 Boston Scientific Corp 111

10.12.1 Company Overview 111

11 Neurology Devices Market Pipeline Products 112

12 Financial Deals Landscape 116

12.1 Equity Offerings 116

12.1.1 Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares 116

12.1.2 Neurotech International Raises USD5.3 Million in IPO of Shares 117

12.2 Venture Financing 118

12.2.1 Saluda Medical Raises USD39.4 Million in Series D Financing 118

13 Recent Developments 119

13.1 Corporate Communications 119

13.1.1 May 24, 2017: Brain Resource appoints a financial services business leader as Director of Finance and Operations 119

13.1.2 May 23, 2017: Brain Resource appoints an experienced global digital business leader as Chief Executive Officer 119

13.1.3 Feb 22, 2017: Compumedics USA Management Strengthened to Deliver Core Business Growth 120

13.2 Financial Announcements 120

13.2.1 Feb 28, 2017: Compumedics Announces Financial Results For Half-Year Ended 31 December 2016 120

13.2.2 Jul 18, 2016: On track for increased sales and profits in FY16 Further growth expected in FY17 122

13.3 Government and Public Interest 122

13.3.1 Jun 15, 2017: Global Kinetics Big Data Highlights Unmet Needs Global Variations in Parkinson's Disease 122

13.3.2 Jul 08, 2016: Computerised Cognitive Test Battery Matches Gold Standard for Hand Screening 123

13.4 Other Significant Developments 123

13.4.1 May 17, 2017: Compumedics: $3 Million In New Orders For China 123

13.4.2 May 17, 2017: Demand for Medibio's corporate wellness technology results in second commercial agreement with Australian Corporate Wellness provider 124

13.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 125

13.4.4 Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre 125

13.4.5 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 126

13.5 Product News 127

13.5.1 Jun 08, 2017: Independent researchers present first data validating Medibio's technology at the prestigious Sleep 2017 127

13.5.2 Aug 02, 2016: Study Provides New Insight into Relationship of Beta Amyloid and Apoe4 to Cognitive Decline 127

13.5.3 Jul 21, 2016: TGA Hazard Alert On Medtronic Neuromodulation Deep Brain Stimulation system pocket adaptors 128

14 Appendix 129

14.1 Research Methodology 130

14.1.1 Coverage 130

14.1.2 Secondary Research 130

14.1.3 Primary Research 131

14.1.4 Company Share Analysis 131

14.1.5 Distribution Share Analysis 131

14.1.6 Benchmarking 132

14.2 GlobalData Consulting 132

14.3 Contact Us 133

14.4 Disclaimer 133


List Of Figure

1.2 List of Figures

Figure 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 13

Figure 2: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 15

Figure 3: Neurology Devices Market, Australia, Volume (Units), Historic, 2009-2016 17

Figure 4: Neurology Devices Market, Australia, Volume (Units), Forecast, 2016-2023 19

Figure 5: Neurology Devices Market, Australia, Company Share (%) 2016 21

Figure 6: CSF Management Market, Australia, Revenue Mix ($m), 2016 23

Figure 7: CSF Management Market, Australia, Segment Contribution (%), 2016 24

Figure 8: CSF Management Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 25

Figure 9: CSF Management Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 27

Figure 10: CSF Management Market, Australia, Volume (Units), Historic, 2009-2016 29

Figure 11: CSF Management Market, Australia, Volume (Units), Forecast, 2016-2023 31

Figure 12: CSF Management Market, Australia, Company Share (%) 2016 34

Figure 13: Interventional Neurology Market, Australia, Revenue Mix ($m), 2016 36

Figure 14: Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37

Figure 15: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 38

Figure 16: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 40

Figure 17: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 42

Figure 18: Navigational System Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44

Figure 19: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46

Figure 20: Navigational System Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Figure 21: Interventional Neurology Market, Australia, Volume (Units), Historic, 2009-2016 50

Figure 22: Interventional Neurology Market, Australia, Volume (Units), Forecast, 2016-2023 52

Figure 23: Embolization and Coiling Devices Market, Australia, Volume (Units), Historic, 2009-2016 54

Figure 24: Navigational System Market, Australia, Volume (Units), Historic, 2009-2016 56

Figure 25: Embolization and Coiling Devices Market, Australia, Volume (Units), Forecast, 2016-2023 58

Figure 26: Navigational System Market, Australia, Volume (Units), Forecast, 2016-2023 60

Figure 27: Interventional Neurology Market, Australia, Company Share (%) 2016 63

Figure 28: Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2016 65

Figure 29: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66

Figure 30: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 67

Figure 31: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 69

Figure 32: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Historic, 2009-2016 71

Figure 33: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Forecast, 2016-2023 73

Figure 34: Neurological Diagnostic Equipment Market, Australia, Company Share (%) 2016 76

Figure 35: Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2016 78

Figure 36: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79

Figure 37: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 80

Figure 38: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 82

Figure 39: Neurostimulation Devices Market, Australia, Volume (Units), Historic, 2009-2016 84

Figure 40: Neurostimulation Devices Market, Australia, Volume (Units), Forecast, 2016-2023 86

Figure 41: Neurostimulation Devices Market, Australia, Company Share (%) 2016 89

Figure 42: Neurosurgical Products Market, Australia, Revenue Mix ($m), 2016 91

Figure 43: Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92

Figure 44: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 93

Figure 45: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 95

Figure 46: Neurosurgical Products Market, Australia, Volume (Units), Historic, 2009-2016 97

Figure 47: Neurosurgical Products Market, Australia, Volume (Units), Forecast, 2016-2023 99

Figure 48: Neurosurgical Products Market, Australia, Company Share (%) 2016 102

Figure 49: Radiosurgery Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 104

Figure 50: Radiosurgery Market, Australia, Volume (Units), Historic, 2009-2016 106


List Of Table

1.1 List of Tables

Table 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 14

Table 2: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 16

Table 3: Neurology Devices Market, Australia, Volume (Units), Historic, 2009-2016 18

Table 4: Neurology Devices Market, Australia, Volume (Units), Forecast, 2016-2023 20

Table 5: Neurology Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 22

Table 6: CSF Management Market, Australia, Segment Contribution (%), 2016 24

Table 7: CSF Management Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 26

Table 8: CSF Management Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 28

Table 9: CSF Management Market, Australia, Volume (Units), Historic, 2009-2016 30

Table 10: CSF Management Market, Australia, Volume (Units), Forecast, 2016-2023 32

Table 11: CSF Management Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 33

Table 12: CSF Management Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 35

Table 13: Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37

Table 14: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 39

Table 15: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 41

Table 16: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43

Table 17: Navigational System Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 45

Table 18: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Table 19: Navigational System Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 49

Table 20: Interventional Neurology Market, Australia, Volume (Units), Historic, 2009-2016 51

Table 21: Interventional Neurology Market, Australia, Volume (Units), Forecast, 2016-2023 53

Table 22: Embolization and Coiling Devices Market, Australia, Volume (Units), Historic, 2009-2016 55

Table 23: Navigational System Market, Australia, Volume (Units), Historic, 2009-2016 57

Table 24: Embolization and Coiling Devices Market, Australia, Volume (Units), Forecast, 2016-2023 59

Table 25: Navigational System Market, Australia, Volume (Units), Forecast, 2016-2023 61

Table 26: Interventional Neurology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 62

Table 27: Interventional Neurology Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 64

Table 28: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66

Table 29: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 68

Table 30: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 70

Table 31: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Historic, 2009-2016 72

Table 32: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Forecast, 2016-2023 74

Table 33: Neurological Diagnostic Equipment Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 75

Table 34: Neurological Diagnostic Equipment Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 77

Table 35: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79

Table 36: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 81

Table 37: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 83

Table 38: Neurostimulation Devices Market, Australia, Volume (Units), Historic, 2009-2016 85

Table 39: Neurostimulation Devices Market, Australia, Volume (Units), Forecast, 2016-2023 87

Table 40: Neurostimulation Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 88

Table 41: Neurostimulation Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 90

Table 42: Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92

Table 43: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 94

Table 44: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 96

Table 45: Neurosurgical Products Market, Australia, Volume (Units), Historic, 2009-2016 98

Table 46: Neurosurgical Products Market, Australia, Volume (Units), Forecast, 2016-2023 100

Table 47: Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 101

Table 48: Neurosurgical Products Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 103

Table 49: Radiosurgery Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 105

Table 50: Radiosurgery Market, Australia, Volume (Units), Historic, 2009-2016 107

Table 51: Radiosurgery Market, Australia, Average Price ($), Historic, 2009-2016 108

Table 52: Neurology Devices Market Pipeline Products 112

Table 53: Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares 116

Table 54: Neurotech International Raises USD5.3 Million in IPO of Shares 117

Table 55: Saluda Medical Raises USD39.4 Million in Series D Financing 118

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH Co KG, MIZUHO Co., Ltd., W. L. Gore Associates Inc, Sophysa SA


Companies

Medtronic Plc

B. Braun Melsungen AG

Natus Medical Incorporated

Integra LifeSciences Holdings Corp

Stryker Corporation

DePuy Synthes Inc

Terumo Corp

Compumedics Ltd

St. Jude Medical LLC

Nihon Kohden Corp

LivaNova PLC

Boston Scientific Corp

Company Profile

Company Profile Title

Australia Neurology Devices Market Outlook to 2023-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Summary

GlobalData's new report, "Australia Neurology Devices Market Outlook to 2023", provides key market data on the Australia Neurology Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Neurology Devices market categories-CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the Australia Neurology Devices market.

Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC, LivaNova PLC and Others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Neurology Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 10

3 Neurology Devices Market, Australia 13

3.1 Neurology Devices Market, Australia, Revenue ($m), 2009-2016 13

3.2 Neurology Devices Market, Australia, Revenue ($m), 2016-2023 15

3.3 Neurology Devices Market, Australia, Volume (Units), 2009-2016 17

3.4 Neurology Devices Market, Australia, Volume (Units), 2016-2023 19

3.5 Neurology Devices Market, Australia, Company Share by Revenue ($m), 2016 21

4 CSF Management Market, Australia 23

4.1 CSF Management Market, Australia, Revenue Mix ($m), 2016 23

4.2 CSF Management Market, Australia, Segment Contribution (%), 2016 24

4.3 CSF Management Market, Australia, Revenue ($m), 2009-2016 25

4.4 CSF Management Market, Australia, Revenue ($m), 2016-2023 27

4.5 CSF Management Market, Australia, Volume (Units), 2009-2016 29

4.6 CSF Management Market, Australia, Volume (Units), 2016-2023 31

4.7 CSF Management Market, Australia, Distribution Share by Revenue ($m), 2015-2016 33

4.8 CSF Management Market, Australia, Company Share by Revenue ($m), 2016 34

5 Interventional Neurology Market, Australia 36

5.1 Interventional Neurology Market, Australia, Revenue Mix ($m), 2016 36

5.2 Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37

5.3 Interventional Neurology Market, Australia, Revenue ($m), 2009-2016 38

5.4 Interventional Neurology Market, Australia, Revenue ($m), 2016-2023 40

5.4.1 Embolization and Coiling Devices Market, Australia, Revenue ($m), by Segment, 2009-2016 42

5.4.2 Navigational System Market, Australia, Revenue ($m), by Segment, 2009-2016 44

5.4.3 Embolization and Coiling Devices Market, Australia, Revenue ($m), by Segment, 2016-2023 46

5.4.4 Navigational System Market, Australia, Revenue ($m), by Segment, 2016-2023 48

5.5 Interventional Neurology Market, Australia, Volume (Units), 2009-2016 50

5.6 Interventional Neurology Market, Australia, Volume (Units), 2016-2023 52

5.6.1 Embolization and Coiling Devices Market, Australia, Volume (Units), by Segment, 2009-2016 54

5.6.2 Navigational System Market, Australia, Volume (Units), by Segment, 2009-2016 56

5.6.3 Embolization and Coiling Devices Market, Australia, Volume (Units), by Segment, 2016-2023 58

5.6.4 Navigational System Market, Australia, Volume (Units), by Segment, 2016-2023 60

5.7 Interventional Neurology Market, Australia, Distribution Share by Revenue ($m), 2015-2016 62

5.8 Interventional Neurology Market, Australia, Company Share by Revenue ($m), 2016 63

6 Neurological Diagnostic Equipment Market, Australia 65

6.1 Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2016 65

6.2 Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66

6.3 Neurological Diagnostic Equipment Market, Australia, Revenue ($m), 2009-2016 67

6.4 Neurological Diagnostic Equipment Market, Australia, Revenue ($m), 2016-2023 69

6.5 Neurological Diagnostic Equipment Market, Australia, Volume (Units), 2009-2016 71

6.6 Neurological Diagnostic Equipment Market, Australia, Volume (Units), 2016-2023 73

6.7 Neurological Diagnostic Equipment Market, Australia, Distribution Share by Revenue ($m), 2015-2016 75

6.8 Neurological Diagnostic Equipment Market, Australia, Company Share by Revenue ($m), 2016 76

7 Neurostimulation Devices Market, Australia 78

7.1 Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2016 78

7.2 Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79

7.3 Neurostimulation Devices Market, Australia, Revenue ($m), 2009-2016 80

7.4 Neurostimulation Devices Market, Australia, Revenue ($m), 2016-2023 82

7.5 Neurostimulation Devices Market, Australia, Volume (Units), 2009-2016 84

7.6 Neurostimulation Devices Market, Australia, Volume (Units), 2016-2023 86

7.7 Neurostimulation Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 88

7.8 Neurostimulation Devices Market, Australia, Company Share by Revenue ($m), 2016 89

8 Neurosurgical Products Market, Australia 91

8.1 Neurosurgical Products Market, Australia, Revenue Mix ($m), 2016 91

8.2 Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92

8.3 Neurosurgical Products Market, Australia, Revenue ($m), 2009-2016 93

8.4 Neurosurgical Products Market, Australia, Revenue ($m), 2016-2023 95

8.5 Neurosurgical Products Market, Australia, Volume (Units), 2009-2016 97

8.6 Neurosurgical Products Market, Australia, Volume (Units), 2016-2023 99

8.7 Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), 2015-2016 101

8.8 Neurosurgical Products Market, Australia, Company Share by Revenue ($m), 2016 102

9 Radiosurgery Market, Australia 104

9.1 Radiosurgery Market, Australia, Revenue ($m), 2009-2016 104

9.2 Radiosurgery Market, Australia, Volume (Units), 2009-2016 106

9.3 Radiosurgery Market, Australia, Average Price ($), 2009-2016 108

10 Overview of Key Companies in Australia, Neurology Devices Market 109

10.1 Medtronic Plc 109

10.1.1 Company Overview 109

10.2 B. Braun Melsungen AG 109

10.2.1 Company Overview 109

10.3 Natus Medical Incorporated 109

10.3.1 Company Overview 109

10.4 Integra LifeSciences Holdings Corp 109

10.4.1 Company Overview 109

10.5 Stryker Corporation 110

10.5.1 Company Overview 110

10.6 DePuy Synthes Inc 110

10.6.1 Company Overview 110

10.7 Terumo Corp 110

10.7.1 Company Overview 110

10.8 Compumedics Ltd 110

10.8.1 Company Overview 110

10.9 St. Jude Medical LLC 111

10.9.1 Company Overview 111

10.10 Nihon Kohden Corp 111

10.10.1 Company Overview 111

10.11 LivaNova PLC 111

10.11.1 Company Overview 111

10.12 Boston Scientific Corp 111

10.12.1 Company Overview 111

11 Neurology Devices Market Pipeline Products 112

12 Financial Deals Landscape 116

12.1 Equity Offerings 116

12.1.1 Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares 116

12.1.2 Neurotech International Raises USD5.3 Million in IPO of Shares 117

12.2 Venture Financing 118

12.2.1 Saluda Medical Raises USD39.4 Million in Series D Financing 118

13 Recent Developments 119

13.1 Corporate Communications 119

13.1.1 May 24, 2017: Brain Resource appoints a financial services business leader as Director of Finance and Operations 119

13.1.2 May 23, 2017: Brain Resource appoints an experienced global digital business leader as Chief Executive Officer 119

13.1.3 Feb 22, 2017: Compumedics USA Management Strengthened to Deliver Core Business Growth 120

13.2 Financial Announcements 120

13.2.1 Feb 28, 2017: Compumedics Announces Financial Results For Half-Year Ended 31 December 2016 120

13.2.2 Jul 18, 2016: On track for increased sales and profits in FY16 Further growth expected in FY17 122

13.3 Government and Public Interest 122

13.3.1 Jun 15, 2017: Global Kinetics Big Data Highlights Unmet Needs Global Variations in Parkinson's Disease 122

13.3.2 Jul 08, 2016: Computerised Cognitive Test Battery Matches Gold Standard for Hand Screening 123

13.4 Other Significant Developments 123

13.4.1 May 17, 2017: Compumedics: $3 Million In New Orders For China 123

13.4.2 May 17, 2017: Demand for Medibio's corporate wellness technology results in second commercial agreement with Australian Corporate Wellness provider 124

13.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 125

13.4.4 Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre 125

13.4.5 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 126

13.5 Product News 127

13.5.1 Jun 08, 2017: Independent researchers present first data validating Medibio's technology at the prestigious Sleep 2017 127

13.5.2 Aug 02, 2016: Study Provides New Insight into Relationship of Beta Amyloid and Apoe4 to Cognitive Decline 127

13.5.3 Jul 21, 2016: TGA Hazard Alert On Medtronic Neuromodulation Deep Brain Stimulation system pocket adaptors 128

14 Appendix 129

14.1 Research Methodology 130

14.1.1 Coverage 130

14.1.2 Secondary Research 130

14.1.3 Primary Research 131

14.1.4 Company Share Analysis 131

14.1.5 Distribution Share Analysis 131

14.1.6 Benchmarking 132

14.2 GlobalData Consulting 132

14.3 Contact Us 133

14.4 Disclaimer 133


List Of Figure

1.2 List of Figures

Figure 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 13

Figure 2: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 15

Figure 3: Neurology Devices Market, Australia, Volume (Units), Historic, 2009-2016 17

Figure 4: Neurology Devices Market, Australia, Volume (Units), Forecast, 2016-2023 19

Figure 5: Neurology Devices Market, Australia, Company Share (%) 2016 21

Figure 6: CSF Management Market, Australia, Revenue Mix ($m), 2016 23

Figure 7: CSF Management Market, Australia, Segment Contribution (%), 2016 24

Figure 8: CSF Management Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 25

Figure 9: CSF Management Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 27

Figure 10: CSF Management Market, Australia, Volume (Units), Historic, 2009-2016 29

Figure 11: CSF Management Market, Australia, Volume (Units), Forecast, 2016-2023 31

Figure 12: CSF Management Market, Australia, Company Share (%) 2016 34

Figure 13: Interventional Neurology Market, Australia, Revenue Mix ($m), 2016 36

Figure 14: Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37

Figure 15: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 38

Figure 16: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 40

Figure 17: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 42

Figure 18: Navigational System Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44

Figure 19: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46

Figure 20: Navigational System Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Figure 21: Interventional Neurology Market, Australia, Volume (Units), Historic, 2009-2016 50

Figure 22: Interventional Neurology Market, Australia, Volume (Units), Forecast, 2016-2023 52

Figure 23: Embolization and Coiling Devices Market, Australia, Volume (Units), Historic, 2009-2016 54

Figure 24: Navigational System Market, Australia, Volume (Units), Historic, 2009-2016 56

Figure 25: Embolization and Coiling Devices Market, Australia, Volume (Units), Forecast, 2016-2023 58

Figure 26: Navigational System Market, Australia, Volume (Units), Forecast, 2016-2023 60

Figure 27: Interventional Neurology Market, Australia, Company Share (%) 2016 63

Figure 28: Neurological Diagnostic Equipment Market, Australia, Revenue Mix ($m), 2016 65

Figure 29: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66

Figure 30: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 67

Figure 31: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 69

Figure 32: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Historic, 2009-2016 71

Figure 33: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Forecast, 2016-2023 73

Figure 34: Neurological Diagnostic Equipment Market, Australia, Company Share (%) 2016 76

Figure 35: Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2016 78

Figure 36: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79

Figure 37: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 80

Figure 38: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 82

Figure 39: Neurostimulation Devices Market, Australia, Volume (Units), Historic, 2009-2016 84

Figure 40: Neurostimulation Devices Market, Australia, Volume (Units), Forecast, 2016-2023 86

Figure 41: Neurostimulation Devices Market, Australia, Company Share (%) 2016 89

Figure 42: Neurosurgical Products Market, Australia, Revenue Mix ($m), 2016 91

Figure 43: Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92

Figure 44: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 93

Figure 45: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 95

Figure 46: Neurosurgical Products Market, Australia, Volume (Units), Historic, 2009-2016 97

Figure 47: Neurosurgical Products Market, Australia, Volume (Units), Forecast, 2016-2023 99

Figure 48: Neurosurgical Products Market, Australia, Company Share (%) 2016 102

Figure 49: Radiosurgery Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 104

Figure 50: Radiosurgery Market, Australia, Volume (Units), Historic, 2009-2016 106


List Of Table

1.1 List of Tables

Table 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 14

Table 2: Neurology Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 16

Table 3: Neurology Devices Market, Australia, Volume (Units), Historic, 2009-2016 18

Table 4: Neurology Devices Market, Australia, Volume (Units), Forecast, 2016-2023 20

Table 5: Neurology Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 22

Table 6: CSF Management Market, Australia, Segment Contribution (%), 2016 24

Table 7: CSF Management Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 26

Table 8: CSF Management Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 28

Table 9: CSF Management Market, Australia, Volume (Units), Historic, 2009-2016 30

Table 10: CSF Management Market, Australia, Volume (Units), Forecast, 2016-2023 32

Table 11: CSF Management Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 33

Table 12: CSF Management Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 35

Table 13: Interventional Neurology Market, Australia, Segment Contribution (%), 2016 37

Table 14: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 39

Table 15: Interventional Neurology Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 41

Table 16: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43

Table 17: Navigational System Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 45

Table 18: Embolization and Coiling Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Table 19: Navigational System Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 49

Table 20: Interventional Neurology Market, Australia, Volume (Units), Historic, 2009-2016 51

Table 21: Interventional Neurology Market, Australia, Volume (Units), Forecast, 2016-2023 53

Table 22: Embolization and Coiling Devices Market, Australia, Volume (Units), Historic, 2009-2016 55

Table 23: Navigational System Market, Australia, Volume (Units), Historic, 2009-2016 57

Table 24: Embolization and Coiling Devices Market, Australia, Volume (Units), Forecast, 2016-2023 59

Table 25: Navigational System Market, Australia, Volume (Units), Forecast, 2016-2023 61

Table 26: Interventional Neurology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 62

Table 27: Interventional Neurology Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 64

Table 28: Neurological Diagnostic Equipment Market, Australia, Segment Contribution (%), 2016 66

Table 29: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 68

Table 30: Neurological Diagnostic Equipment Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 70

Table 31: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Historic, 2009-2016 72

Table 32: Neurological Diagnostic Equipment Market, Australia, Volume (Units), Forecast, 2016-2023 74

Table 33: Neurological Diagnostic Equipment Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 75

Table 34: Neurological Diagnostic Equipment Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 77

Table 35: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2016 79

Table 36: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 81

Table 37: Neurostimulation Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 83

Table 38: Neurostimulation Devices Market, Australia, Volume (Units), Historic, 2009-2016 85

Table 39: Neurostimulation Devices Market, Australia, Volume (Units), Forecast, 2016-2023 87

Table 40: Neurostimulation Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 88

Table 41: Neurostimulation Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 90

Table 42: Neurosurgical Products Market, Australia, Segment Contribution (%), 2016 92

Table 43: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 94

Table 44: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 96

Table 45: Neurosurgical Products Market, Australia, Volume (Units), Historic, 2009-2016 98

Table 46: Neurosurgical Products Market, Australia, Volume (Units), Forecast, 2016-2023 100

Table 47: Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 101

Table 48: Neurosurgical Products Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 103

Table 49: Radiosurgery Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 105

Table 50: Radiosurgery Market, Australia, Volume (Units), Historic, 2009-2016 107

Table 51: Radiosurgery Market, Australia, Average Price ($), Historic, 2009-2016 108

Table 52: Neurology Devices Market Pipeline Products 112

Table 53: Optiscan Imaging Raises USD1.4 Million in Private Placement of Shares 116

Table 54: Neurotech International Raises USD5.3 Million in IPO of Shares 117

Table 55: Saluda Medical Raises USD39.4 Million in Series D Financing 118

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH Co KG, MIZUHO Co., Ltd., W. L. Gore Associates Inc, Sophysa SA


Companies

Medtronic Plc

B. Braun Melsungen AG

Natus Medical Incorporated

Integra LifeSciences Holdings Corp

Stryker Corporation

DePuy Synthes Inc

Terumo Corp

Compumedics Ltd

St. Jude Medical LLC

Nihon Kohden Corp

LivaNova PLC

Boston Scientific Corp